Treating painful diabetic neuropathy with gabapentin.
Brooks-Rock
K
K
D000085:Acetates / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000588:Amines; D000700:Analgesics / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D003929:Diabetic Neuropathies / Q000150:complications*; D004305:Dose-Response Relationship, Drug; D016527:Drug Costs; D000077206:Gabapentin; D006801:Humans; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D010147:Pain Measurement; D018579:Patient Selection; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin